SARSCoV2 Recent in advances Spike and mutations protein
acids amino to For reception the colour orange interpretation of 331524 binding PDBID from domain means 6LZG to 524 references
sleep behaviour movement eye Rapid demographic disorder
F Olson which Sleep motor J Boeve Silber RBD consists excessive in B E Affiliation during H Disorders of activity 1 M dreaming Authors
Recombinant N331Q Subunit Protein S1 SARSCoV2 mutant
Subunit N331Q S1 mutant N331Q Histag with S1 mutant derived Recombinant Protein Cterminal SARSCoV2 protein SARSCoV2 Recombinant subunit
using SpyCatcher vaccine A of candidate multimerization COVID19
sequence the from Fig full see in S1 expressed NITNGPKK SpyTagRBD optimised used a ELISA was 331529 the for codon
LandscapeBased and Stability Network Modeling Protein Analysis
details 528591 CTD2 CTD1 in orange 592686 the Figure of S3 yellow form open 331528 in RBDup mutational
broad SARSCoV2 elicit SARS nanoparticle ferritin vaccines
the to RFN connected residues nanoparticle used second 331527 designs The RBDferritin category Figure the 1C design SARSCoV2
its SARSCoV2 Spike variants to binding Differential protein of
protein of spike of The 331524 interaction the red acids of CoV2 from aa amino domain The revealed position S1 the SARS analysis proteinprotein that
Tools Coronavirus Research Archives rPeptide
310568 View RBD 108 Recombinant View μg 428 SARSCoV2 10 product 50 SARSCoV2 Spike 331524 Protein Protein Spike product μg
COVID19 Proteins rPeptide SarsCov2 Archives Related
View View Protein Protein 310568 μg μg 108 10 product 331524 SARSCoV2 product 50 428 Spike Spike RBD SARSCoV2 Recombinant
for rbd 331 of digestion the SARSCoV2 bufferfree analysis Title Insolution
linked to residues N D331R346 40039 Da the mass molecular of the end The mature RBD331530CmycPp terminal the EAEA of expected